4
Changes in Ownership
ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-25-042855
CEO sold 6,276 shares at $2.98 ($18,721)
From the SEC's structured data for this filing
Trades in this filing
Shah Gaurav · CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-18 | Sale : show line 1 in the form | −6,276 | $2.98 | $18,721 | 778,296 | D |
| Open-market sales · 6,276 sh · avg $2.98 · $18,721 | ||||||
Loading xslF345X05/form4.xml…